Related references
Note: Only part of the references are listed.Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
HMGB1 in Cancer: Good, Bad, or Both?
Rui Kang et al.
CLINICAL CANCER RESEARCH (2013)
The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients
Xiaojing Xu et al.
LUNG CANCER (2013)
HMGB1gene polymorphisms in patients with chronic hepatitis B virus infection
Chun-Qing Deng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
Yoshiyuki Suzuki et al.
CANCER RESEARCH (2012)
Genetic polymorphism of copper transporter protein 1 is related to platinum resistance in Chinese non-small cell lung carcinoma patients
Xiaojing Xu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients
Xiaojing Xu et al.
LUNG CANCER (2012)
Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Patients
Ji-Ye Yin et al.
PLOS ONE (2012)
Clinical relevance of single nucleotide polymorphisms of the high mobility group box 1 protein gene in patients with major trauma in Southwest China
Ling Zeng et al.
SURGERY (2012)
HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
Ulf Andersson et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
HMGB proteins and transcriptional regulation
Tetsuya Ueda et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
High-mobility group box 1 and cancer
Daolin Tang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Association of HMGB1 Polymorphisms with Outcome after Allogeneic Hematopoietic Cell Transplantation
Brian Kornblit et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Association of DNA Repair Gene Polymorphisms With Response to Platinum-Based Doublet Chemotherapy in Patients With Non-Small-Cell Lung Cancer
Kouya Shiraishi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Integrating common and rare genetic variation in diverse human populations
David M. Altshuler et al.
NATURE (2010)
DNA Repair Gene Polymorphisms Predict Favorable Clinical Outcome in Advanced Non-Small-Cell Lung Cancer
Aristea Kalikaki et al.
CLINICAL LUNG CANCER (2009)
Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy
Wojciech Naumnik et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2009)
Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
Natalia F. Krynetskaia et al.
MOLECULAR CANCER THERAPEUTICS (2009)
HMGB1: The Jack-of-All-Trades Protein Is a Master DNA Repair Mechanic
Sabine S. Lange et al.
MOLECULAR CARCINOGENESIS (2009)
Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphisms in Chinese population
Ji-Ye Yin et al.
PHARMACOGENETICS AND GENOMICS (2009)
Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer
Guan-Hong Shang et al.
RESPIRATORY MEDICINE (2009)
Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin -: Treated advanced non-small cell lung cancer patients
Carmelo Tibaldi et al.
CLINICAL CANCER RESEARCH (2008)
The plasticity of estrogen receptor-DNA complexes: Binding affinity and specificity of estrogen receptors to estrogen response element half-sites separated by variant spacers
S. El Marzouk et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome
Brian Kornblit et al.
CRITICAL CARE (2008)
Growth suppression and radiosensitivity increase by HMGB1 in breast cancer
Yang Jiao et al.
ACTA PHARMACOLOGICA SINICA (2007)
The genetic variation of the human HMGB1 gene
B. Kornblit et al.
TISSUE ANTIGENS (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Functional significance of the TLR4/11367 polymorphism identified in Chinese Han population
Zhao-xia Duan et al.
SHOCK (2007)
Mechanisms of resistance to cisplatin and carboplatin
David J. Stewart
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Understanding cisplatin resistance using cellular models
Britta Stordal et al.
IUBMB LIFE (2007)
Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin
Ji-Youn Han et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Pharmacogenetics for individualized cancer chemotherapy
T Efferth et al.
PHARMACOLOGY & THERAPEUTICS (2005)
High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal
MT Lotze et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma
B Bartling et al.
CARCINOGENESIS (2005)
v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoter
O Chayka et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Drug therapy: Multidisciplinary management of lung cancer
A Spira et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Molecular mechanisms of platinum resistance: still searching for the Achilles' heel
RP Wernyj et al.
DRUG RESISTANCE UPDATES (2004)
Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein
K McKinney et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Staging small cell lung cancer: Veterans administration lung study group versus international association for the study of lung cancer-what limits limited disease?
P Micke et al.
LUNG CANCER (2002)
HMGB1 and HMGB2 cell-specifically down-regulate the p53-and p73-dependent sequence-specific transactivation from the human Bax gene promoter
M Stros et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The human HMGB1 promoter is modulated by a silencer and an enhancer-containing intron
HK Lum et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2001)
Dual roles for HMGB1: DNA binding and cytokine
CJ Czura et al.
JOURNAL OF ENDOTOXIN RESEARCH (2001)
Share Paper
